(Alliance News) - Genflow Biosciences PLC on Tuesday said it has secured EUR4 million in funding from the Wallonia region in Belgium, to support its gene therapy development work. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - Genflow Biosciences PLC on Thursday said that it has received half of its grant funding from the Government of Wallonia in Belgium's Advanced Therapy Medicinal Products. Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and Wednesday, and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of earnings and trading updates by London-listed companies, issued on Tuesday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - Genflow Biosciences PLC on Thursday said its collaborative partners, which include University of Rochester, Columbia University and Albert Einstein College of Medicine, have received confirmation that their European patent application has been approved for SIRT6. Read More
(Alliance News) - The following is a round-up of trading updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Thursday and not separately reported by Alliance News: Read More
(Alliance News) - Genflow Biosciences PLC on Thursday said loss narrowed in the first half of 2023, as it managed to slash administrative expenses. Read More
(Alliance News) - The following is a round-up of updates by London-listed companies, issued on Wednesday and not separately reported by Alliance News: Read More
(Alliance News) - Genflow Biosciences PLC on Tuesday said it began trading on the OTCQB Venture Market in the US, in addition to its London Stock Exchange Main Market listing. Read More
Genflow Biosciences - London-based biotechnology company focused on longevity, with research & development facilities in Belgium - Names Tamara Joseph, a US-based non-executive director, as new chair. Points out Joseph has an impressive track record in public and private financings, having supported Nasdaq financings in excess of USD800 million. Read More
(Alliance News) - Genflow Biosciences PLC shares jumped on Wednesday, after it said it has submitted an application for trading of its shares on the OTCQB Venture Market in the US. Read More
(Alliance News) - Genflow Biosciences PLC on Tuesday praised a "resurgence of interest in the longevity sector", positively noting a secure financial position. Read More
